首页 > 用药指导 > 文章详情

Baricitinib(艾乐明)巴瑞替尼国内的价格是多少

发布时间:2023-12-10 18:22:23 阅读:894 来源:问药网
分享至

分享到微信朋友圈

×

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

巴瑞替尼片

巴瑞替尼片 生产厂家:孟加拉碧康制药股份有限公司 功能主治:对一种或多种抗风湿药物缓解不足或不耐受的中度至重 用法用量:用法用量  1、类风湿性关节炎  OLUMIANT的推荐剂量为每日1次口服2mg,餐前餐后都可。  OLUMIANT可以单独使用,也可以与甲氨蝶呤或其他非生物dmard联合使用。  2、COVID-19(新冠病毒)  成人OLUMIANT的推荐剂量为每日一次口服4mg,餐前餐后都可,持续14天或直到出院,以先发生者为准。  3、斑秃  OLUMIANT的推荐剂量是2mg,每天一次口服,餐前餐后都可。  如果对治疗的反应不充分,增加到每天一次4mg。  对于几乎完全或完全的头皮脱发,睫毛或眉毛有或没有大量脱发的患者,考虑每天一次4mg治疗,伴餐前餐后都可。  一旦患者对4mg的治疗产生了充分的反应,将剂量减少到2mg,每天一次。  对于无法吞下整片药片的患者,可以考虑另一种给药方式:  1、口服分散  2、胃造口管(G管)  3、鼻胃管(NG管)或口胃管(OG管)
查看详情

Baricitinib(艾乐明)巴瑞替尼国内的价格是多少,Baricitinib(Baricitinib)的版本有:1、孟加拉耀品国际版本;2、孟加拉伊思达版本;3、印度natco版本;4、孟加拉方圆版本;5、孟加拉碧康制药版本。代购价格是380元左右,不同版本价格不同,以实际为准。请选择正规海外代购渠道,以保证产品质量。

Baricitinib (艾乐明), also known as Baricitinib tablets, is a medication used for the treatment of rheumatoid arthritis, COVID-19 (caused by the novel coronavirus), and alopecia areata (spot baldness). In this article, we will explore the current price of Baricitinib in the domestic market in China.

The price of Baricitinib in China:

According to the latest information available, the price of Baricitinib tablets in China varies depending on the dosage strength and packaging size. As of now, the average market price for a 2 mg Baricitinib tablet in China ranges from approximately 80 to 120 RMB (Renminbi). It's important to note that drug prices may fluctuate over time due to various factors, including currency exchange rates, manufacturing costs, and market demand. It is always advisable to consult with healthcare professionals or visit authorized pharmacies for the most accurate and up-to-date pricing information.

1. Baricitinib for Rheumatoid Arthritis:

Baricitinib has been approved for the treatment of rheumatoid arthritis in China. Rheumatoid arthritis is a chronic autoimmune disorder that primarily affects the joints, causing pain, swelling, and stiffness. Baricitinib works by reducing inflammation and modifying the immune response, which helps to relieve the symptoms of rheumatoid arthritis. The availability of Baricitinib provides an additional treatment option for patients with this condition.

2. Baricitinib for COVID-19:

During the COVID-19 pandemic, Baricitinib gained attention as a potential treatment for severe cases. It was shown to have anti-inflammatory properties and the ability to inhibit viral replication, making it a promising candidate for COVID-19 treatment. In certain situations, Baricitinib is used in combination with other drugs, such as Remdesivir, for hospitalized patients with severe COVID-19. The cost of Baricitinib for COVID-19 treatment may vary depending on the hospital and healthcare system's policies.

3. Baricitinib for Alopecia Areata:

Alopecia areata, commonly known as spot baldness, is an autoimmune condition that causes hair loss, often in patches. Baricitinib has shown positive results in treating alopecia areata, with studies indicating hair regrowth and improvement in affected individuals. The use of Baricitinib for alopecia areata is under investigation, and it may require a prescription from a specialist dermatologist.

In conclusion, the current price of Baricitinib tablets in China ranges from approximately 80 to 120 RMB for a 2 mg tablet. The availability of Baricitinib provides new treatment options for patients with rheumatoid arthritis, COVID-19, and alopecia areata. However, it is essential to consult with healthcare professionals and rely on accurate and up-to-date pricing information for specific cases.

孟加拉碧康制药股份有限公司碧康制药股份有限公司(Beacon,简称碧康制药)创建设于2001年,是孟加拉目前规模最大、技术最先进的抗肿瘤类和抗病毒类药物生产企业,也是该国成长最快的大型制药龙头企业。
直达企业主页

热门文章

更多